Want to join the conversation?
For FY17, $MNRO expects sales to be in the range of $0.98-1.01Bil and diluted EPS to be in the range of $2.05-2.20. For 1Q17, the company anticipates sales to be in the range of $230-240MM, with comparable store sales to fall 8.0% to 5.0%. Diluted EPS for 1Q17 is expected to be between $0.47-0.51 vs. $0.57 in 1Q16.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?